Latigo Biotherapeutics, Inc. (LTGO) Stock

NASDAQ: LTGOHealthcare company in the biotechnology industry, based in Thousand Oaks, CA.

Latigo Biotherapeutics stock price chart

LTGO interactive chart →

LTGO stock quote & key statistics

Latigo Biotherapeutics earnings per share

Income →
Earnings per share

Latigo Biotherapeutics revenue & net income

Income →
RevenueNet income

Latigo Biotherapeutics annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$0-$109.2M—
FY2024$0-$61.2M—

Fiscal year ending December 31. Source: company filings via EODHD.

About Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company's pipeline includes LTG-001, an oral NaV1.8 inhibitor designed to provide fast-acting, opioid-sparing relief for the treatment of acute pain; LTG-321, a NaV1.8 inhibitor candidate developed for the treatment of chronic musculoskeletal pain, starting with osteoarthritis; and LTG-418, a NaV1.8 inhibitor developed for the treatment of acute and chronic pain.

Latigo Biotherapeutics, Inc. was formerly known as WVB-Desmond, Inc. and changed its name to Latigo Biotherapeutics, Inc. in March 2019. Latigo Biotherapeutics, Inc. was incorporated in 2018 and is based in Thousand Oaks, California.

Latigo Biotherapeutics stock FAQ

What is the Latigo Biotherapeutics stock ticker symbol?

Latigo Biotherapeutics, Inc. trades on the NASDAQ under the ticker symbol LTGO.

What sector and industry is Latigo Biotherapeutics in?

Latigo Biotherapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Latigo Biotherapeutics have?

Latigo Biotherapeutics, Inc. has about 66 full-time employees.

What were Latigo Biotherapeutics's revenue and earnings last fiscal year?

Latigo Biotherapeutics reported revenue of $0 and net income of -$109.2M in fiscal 2025.

When did Latigo Biotherapeutics go public?

Latigo Biotherapeutics stock began trading on August 7, 2026.

Biotechnology stocks

All Healthcare stocks →